Truveta

Transform your research with actionable insights from clinical notes! Truveta unlocks data from over 5 billion clinical notes, seamlessly integrating it with structured EHR data for a full view of the patient journey. From disease progression to product safety and health disparities, the possibilities for impactful research are endless. Discover how Truveta extracts data at scale and enables groundbreaking studies into patient outcomes and beyond. 📥 Download the briefing today to learn more! #HealthcareInnovation #ClinicalResearch #DataInsights https://tr.vet/4gVgg0l

Robert Riney, president and CEO, Henry Ford Health on the #TruvetaGenomeProject

Jakob Wedel, Chief Strategy and Corporate Development Officer of Illumina on the #TruvetaGenomeProject

Discover how the #TruvetaGenomeProject is transforming healthcare by moving beyond a "one-size-fits-all" model. With a focus on precision, prediction, and prevention, this project integrates genomic data with electronic health records to revolutionize patient care. By understanding the genetic basis of disease, healthcare providers can develop targeted therapies, personalize treatment plans, and tailor care to an individual’s unique genetic makeup. When paired with advancements in AI, this approach is set to accelerate innovation, unlocking breakthroughs that will dramatically improve outcomes for patients everywhere. Watch to learn how Truveta is leading the charge in personalized medicine and the future of healthcare.

Witness the groundbreaking collaboration between Truveta, its health system members, and the Regeneron Genetics Center, uniting cutting-edge technology, AI, and genetic research to transform healthcare. Truveta’s unmatched health record database represents over 120 million individuals, while the Regeneron Genetics Center leads the world in genomic research into the drivers of human health. By combining these powerful platforms and expertise, this partnership is set to drive unprecedented advancements in science, medicine, and humanity. Watch to see how this collaboration is shaping the future of healthcare innovation. #TruvetaGenomeProject

George D. Yancopoulos, M.D., Ph.D., Board co-Chair, President and Chief Scientific Officer of Regeneron on the #TruvetaGenomeProject

Truveta will be at DIA next week, where Conor Wyand will be sharing our experiences with using daily EHR data to monitor safety. If you’re in Baltimore for the Global Pharmacovigilance and Risk Management Strategies Conference, be sure to catch his session, and set up a meeting with our team on-site here: https://tr.vet/4fmJWC8

The winter respiratory virus season is in full swing. New research from Truveta today shows a significant increase in hospitalizations through the end of December. Here’s what they found: ⬆️Overall hospitalizations associated with respiratory viruses has increased 3-fold since the end of November. 🏥The flu is driving the most hospitalizations – with an 8-fold increase. 👵The flu is greatly impacting adults over 65 – with an 875.8% increase. 🚸RSV continues to impact kids under the age of 5 – with 7.5% of all hospitalizations for kids in this age group associated with RSV. https://tr.vet/4ayLx75

CommonSpirit Health CEO Wright Lassiter III on the #TruvetaGenomeProject

Join us at #SCOPEsummit as we share how our real-world data helps optimize clinical trial strategy. ✅ Build and analyze precise populations with data from 120M+ patients. ✅ Optimize trial design to de-risk programs. ✅ Create real-world control arms with regulatory-grade data. Book a meeting with our team to discuss how Truveta Data can help you validate trial designs and enhance trial data. https://tr.vet/4jdBb0i #SCOPE #ClinicalTrials #RealWorldData #Innovation